K Number
K200836
Device Name
8ch Flex Suite
Date Cleared
2020-07-22

(113 days)

Product Code
Regulation Number
892.1000
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The 1.5T 8ch Flex Suite manufactured by Shenzhen RF Tech Co.,Ltd is receive-only coil and is designed for use as general purpose coil. The 1.5T 8ch Flex Suite is designed to be use with GE 1.5T MRI systems to produce diagnostic images of upper and lower extremities, head, spine and cardiac that can be interpreted by a trained physician.
Device Description
The 1.5T 8ch Flex Suite is receive-only phased array coil for imaging the upper and lower extremities, head and spine in adult population. The 1.5T 8ch Flex Suite consists of three flexible and lightweight coil of different size that can be wrapped or orientated flat, in order to accommodate various anatomic shapes and sizes. The 1.5T 8ch Flex Suite is tuned to receive RF frequency corresponding to the proton precession in a 1.5 Tesla magnetic field, which is governed by the Larmor equation.
More Information

Not Found

No
The document describes a receive-only MRI coil and its physical characteristics and testing. There is no mention of AI or ML in the intended use, device description, or performance studies.

No
The device is described as a receive-only coil designed for use with MRI systems to produce diagnostic images, not to treat any condition.

Yes

This device is a receive-only coil designed to work with MRI systems to produce diagnostic images, which are then interpreted by a trained physician for diagnosis.

No

The device description clearly states it is a "receive-only phased array coil" consisting of "three flexible and lightweight coil of different size," which are physical hardware components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The 1.5T 8ch Flex Suite is an MRI coil. Its function is to receive radiofrequency signals from the body during an MRI scan to produce diagnostic images. It does not analyze biological samples.
  • Intended Use: The intended use is to produce diagnostic images of various anatomical sites, which are then interpreted by a trained physician. This is a function of an imaging device, not an IVD.

Therefore, the 1.5T 8ch Flex Suite falls under the category of a medical imaging device, not an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

The 1.5T 8ch Flex Suite manufactured by Shenzhen RF Tech Co.,Ltd is receive-only coil and is designed for use as general purpose coil. The 1.5T 8ch Flex Suite is designed to be use with GE 1.5T MRI systems to produce diagnostic images of upper and lower extremities, head, spine and cardiac that can be interpreted by a trained physician.

Product codes (comma separated list FDA assigned to the subject device)

MOS

Device Description

The 1.5T 8ch Flex Suite is receive-only phased array coil for imaging the upper and lower extremities, head and spine in adult population. The 1.5T 8ch Flex Suite consists of three flexible and lightweight coil of different size that can be wrapped or orientated flat, in order to accommodate various anatomic shapes and sizes.

The 1.5T 8ch Flex Suite is tuned to receive RF frequency corresponding to the proton precession in a 1.5 Tesla magnetic field, which is governed by the Larmor equation.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Magnetic Resonance Imaging (MRI)

Anatomical Site

upper and lower extremities, head, spine and cardiac

Indicated Patient Age Range

Adult populations

Intended User / Care Setting

Trained physician / Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The following performance data were provided in support of the substantial equivalence determination.

The biocompatibility evaluation was conducted in accordance with ISO International Standard and included cytotoxicity test, sensitization test and irritation test to raw material which will contact with surface skin.

The test for safety and electromagnetic compatibility (EMC), basic safety and performance test were conducted in accordance with IEC and NEMA Standard.

Shelf Life testing and mechanical reliability testing were conducted.

Clinical images evaluation testing for the proposed device was evaluated by connected to compatible MRI system.

Summary: Based on above testing, the proposed 8ch Flex Suite was found to have a safety and effectiveness profile that is similar to the predicate device.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K172222

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.1000 Magnetic resonance diagnostic device.

(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

July 22, 2020

Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Shenzhen RF Tech Co., Ltd. % Mr. Gary Wang Q&R Director 2-F, Bld4, Juhui Industrial Park, Tianliao, Guangming Shenzhen, Guangdong 518132 CHINA

Re: K200836

Trade/Device Name: 8ch Flex Suite Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: Class II Product Code: MOS Dated: June 18, 2020 Received: June 22, 2020

Dear Mr. Wang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for

1

devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

For

Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K200836

Device Name 8ch Flex Suite

Indications for Use (Describe)

The 1.5T 8ch Flex Suite manufactured by Shenzhen RF Tech Co.,Ltd is receive-only coil and is designed for use as general purpose coil. The 1.5T 8ch Flex Suite is designed to be use with GE 1.5T MRI systems to produce diagnostic images of upper and lower extremities, head, spine and cardiac that can be interpreted by a trained physician.

Type of Use (Select one or both, as applicable)Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C)
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff

PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."

3

510(k) Summary

In accordance with 21 CFR 807.92 the following summary of information is provided:

| I. Applicant/Manufacturer | Shenzhen RF Tech Co., Ltd.
2-F,BLD4 Juhui Industrial Park,
Tianliao,Guangming,Shenzhen,
P.R.China 518132
Phone: (+86) 755-2664 1989-113
Fax: (+86)755-2664 2989 |
|----------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter/Correspondent | Shenzhen RF Tech Co., Ltd.
2-F,BLD4 Juhui Industrial Park,
Tianliao,Guangming,Shenzhen,
P.R.China 518132
Phone: (+86) 755-2664 1989-113
Fax: (+86)755-2664 2989 |
| Contact Person: | Mr. Gary Wang
Q&R Director
Shenzhen RF Tech Co., Ltd.
Email: gary.wang@rft.cn |
| II. Name of Device
Common Name of Device: | 8ch Flex Suite |
| Common/Usual Name: | Coil, Magnetic Resonance, Specialty |
| Classification panel: | Radiology |
| Classification Names: | Magnetic Resonance Diagnostic Device |
| Regulation Number: | 21 CFR 892.1000 |
| Regulation Class: | II |
| Product Code: | MOS |
| Type of 510(k) submission: | Traditional 510(k) |
| III. Device Information
Product Number: | Device Trade Name |
| 10-F25061 | 8ch Flex 70 Array |
| 10-F25062 | 8ch Flex 50 Array |
| 10-F25063 | 8ch Flex 40 Array |

4

V. Device Description

The 1.5T 8ch Flex Suite is receive-only phased array coil for imaging the upper and lower extremities, head and spine in adult population. The 1.5T 8ch Flex Suite consists of three flexible and lightweight coil of different size that can be wrapped or orientated flat, in order to accommodate various anatomic shapes and sizes.

The 1.5T 8ch Flex Suite is tuned to receive RF frequency corresponding to the proton precession in a 1.5 Tesla magnetic field, which is governed by the Larmor equation.

Image /page/4/Picture/3 description: The image shows three different versions of what appears to be a white, flexible keyboard-like device with a cable and connector attached. The text labels below each device, "10-F25061", "10-F25062", and "10-F25063", likely represent different model or part numbers. Each device has a similar rectangular shape with segmented sections, resembling keys or pressure-sensitive areas. The cable and connector suggest that the device is electronic and requires a wired connection.

VI. Intended Use

The 1.5T 8ch Flex Suite manufactured by Shenzhen RF Tech Co., Ltd. is receive-only coil and is designed for use as general-purpose coil. The 1.5T 8ch Flex Suite is designed to be use with GE 1.5T MRI systems to produce diagnostic images of upper and lower extremities, head, spine and cardiac that can be interpreted by a trained physician.

VII. Comparison of Technological Characteristics with the Predicated Device

| Specification | Predicate Device | Proposed | Discussion
Difference |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------|
| K number | K172222 | | |
| Device name | 8ch Flex Suite | 8ch Flex Suite | |
| Manufacturer | Shenzhen RF Tech Co.,Ltd | Shenzhen RF Tech Co.,Ltd | |
| Intended Use | The 1.5T 8ch Flex Suite manufactured by Shenzhen
RF Tech Co.,Ltd is receive-only coil and is designed
for use as general purpose coil. The 1.5T 8ch Flex
Suite is designed to be use with GE 1.5T MRI systems
to produce diagnostic images of upper and lower
extremities, head and spine that can be interpreted by
a trained physician. | The 1.5T 8ch Flex Suite manufactured by Shenzhen
RF Tech Co.,Ltd is receive-only coil and is designed
for use as general purpose coil. The 1.5T 8ch Flex
Suite is designed to be use with GE 1.5T MRI systems
to produce diagnostic images of upper and lower
extremities, head, spine and cardiac that can be
interpreted by a trained physician. | Similar |
| Anatomical site | The upper and lower extremities, head and spine in
adult populations that can be interpreted by a trained
physician. | The upper and lower extremities, head, spine and
cardiac in adult populations that can be interpreted by
a trained physician. | Similar |
| Coil type | RF coil (receive only) | RF coil (receive only) | Same |
| Channel | 8 CH | 8 CH | Same |

5

Field strength1.5 T1.5 TSame
RF power16kw16kwSame
amplitudeB1 max =25UTB1 max =25UTSame
rise time330usec330usecSame
slew rate100 T/m/s100 T/m/sSame
shielding80dB80dBSame
cooling12kw(water cooling)12kw(water cooling)Same
preamplifier noise0.5dB0.5dBSame
Storage
temperature-30°C to +55°C-30°C to +55°CSame
Storage humidity5% to 95%5% to 95%Same
Operation
temperature15° C to 21°C15° C to 21°CSame
Operating
humidity30% to 75%30% to 75%Same
Power source+10V+10VSame
BiocompatibilityComply with ISO 10993-5 and ISO 10993-10Comply with ISO 10993-5 and ISO 10993-10Same
Electrical SafetyIEC 60601-1
IEC 60601-1-2IEC 60601-1
IEC 60601-1-2Same
Other: Device
Specific Guidance
Requirements for
ComparisonGuidance for the Submission of Premarket
Notifications for Magnetic Resonance Diagnostic
Devices; FinalGuidance for the Submission of Premarket
Notifications for Magnetic Resonance Diagnostic
Devices; FinalSame

The proposed 8ch Flex Suite can be wrapped around the anatomy of interest and have same design and same technology character with same manufacturing process and material with predicate device. The proposed 8ch Flex Suite is general purpose receive only coil with 8 elements and intergraded preamplifiers. It is same with predicate device

The proposed 8ch Flex Suite is based on phased array technique for combining the images from 8 different channels. The 1.5T 8ch Flex Suite is tuned to the proton frequency of 63.86MHz. It is same with predicate device

The proposed 8ch Flex Suite has similar intended purpose with predicate device.

The difference between proposed 8ch Flex Suite and predicate device is the plug type. The proposed 8ch Flex Suite is P port and predicate device is A port, which is connected to MRI system with different port. The proposed 8ch Flex Suite extended its image scope by adding cardiac image compared to predicate device.

VIII Standard List for Performance Tests

All verification tests have been performed according to below standard, the testing results are passed 1.IEC 60601-1:2005 (Third Edition) + CORR. 1:2006 + CORR. 2:2007 +

A1:2012, Medical electrical equipment - Part 1: General requirements for basic safety and essential 2.IEC 60601-1-2:2014 Medical electrical equipment - Part 1-2: General requirements for safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests; 3.ISO 10993-5:2009: Biological evaluation of medical devices. Part 5-Tests for in vitro cytotoxicity. 4.ISO 10993-10:2010 Biological evaluation of medical devices, Part 10-Tests for irritation and skin

6

sensitization.

5.NEMA MS-1-2008 Determination of Signal-to-Noise Ratio (SNR) in Diagnostic Magnetic Resonance Imaging.

6.NEMA MS 3-2008 Determination of Image Uniformity in Diagnostic Resonance Images.

7.IEC60601-2-33:2010+A1:2013+A2:2015 Medical equipment - Part 2-33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis.

IX. Performance Data

The following performance data were provided in support of the substantial equivalence determination.

The biocompatibility evaluation was conducted in accordance with ISO International Standard and included cytotoxicity test, sensitization test and irritation test to raw material which will contact with surface skin.

The test for safety and electromagnetic compatibility (EMC), basic safety and performance test were conducted in accordance with IEC and NEMA Standard.

Shelf Life testing and mechanical reliability testing were conducted.

Clinical images evaluation testing for the proposed device was evaluated by connected to compatible MRI system.

Summary: Based on above testing, the proposed 8ch Flex Suite was found to have a safety and effectiveness profile that is similar to the predicate device.

X. Conclusion:

Shenzhen RF Tech Co., Ltd. considers the proposed 8ch Flex Suite does not raise any new issues of safety or effectiveness and performs as well as the legally marketed predicate device.